Skip to content

The effects of neo-adjuvant hyperoxic hyperbaric preconditioning on myocardial protection & ischaemic reperfusion injury

The effects of neo-adjuvant hyperoxic hyperbaric preconditioning on myocardial protection & ischaemic reperfusion injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN61606639
Enrollment
128
Registered
2005-09-30
Start date
2004-08-31
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery: Coronary artery bypass grafting (CABG) Surgery Coronary artery bypass grafting (CABG)

Interventions

Patients will be recruited from the cohort of the 4 surgeons at the Cardiothoracic Unit in Castle Hill Hospital. Patients will be recruited at the Out-Patients Clinic and on the ward prior to surgery

Sponsors

Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients will be recruited from the cohort of the 4 surgeons at the Cardiothoracic Unit in Castle Hill Hospital.

Exclusion criteria

Exclusion criteria: 1. Asthma 2. Known intolerance to N acetyl cysteine 3. Serum creatinine greater than 200 mol/L

Design outcomes

Primary

MeasureTime frame
Demonstration of anticipated enhanced protective effect of hyperbaric preconditioning in the heart biopsies as determined by 1. Elevated levels of cellular HSP 72 mRNA, HSP 72 protein 2. Elevated levels of cellular iNOS mRNA, iNOS protein, eNOS mRNA, eNOS protein and total cellular Nitric Oxide 3. Reduced ischemic reperfusion injury as determined by reduced levels of P-selectin, TNF-ALPHA, IL-6 and IL-8 and its mRNA ie. P-selectin mRNA, TNF-ALPHA mRNA, IL-6 mRNA and IL-8 mRNA

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026